GGrantIndex
Sort

82,697 grants matching vaccine development

Developing broad-spectrum therapeutics against C. difficile toxins

$779,693
Rongsheng Jin · University Of California-Irvine · R01 · FY2022 · AI

Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models

$779,687
Matthias Johannes Schnell · Thomas Jefferson University · R01 · FY2022 · AI

Unconventional protein secretion-mediated protein quality control in health and diseases

$779,674
Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection

$779,673
Priyamvada Acharya · Duke University · R01 · FY2022 · AI

Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.

$779,645
Joseph A Duncan · Univ Of North Carolina Chapel Hill · U01 · FY2023 · AI

Small Molecule Inhibitors of Ebola Virus Polymerase Function

$779,570
Christopher F Basler · Georgia State University · R01 · FY2019 · AI

Small Molecule Inhibitors of Ebola Virus Polymerase Function

$779,568
Christopher F Basler · Georgia State University · R01 · FY2020 · AI

O-Specific Polysaccharide Responses and Cholera

$779,448
Edward T. Ryan · Massachusetts General Hospital · R01 · FY2018 · AI

O-Specific Polysaccharide Responses and Cholera

$779,448
Edward T. Ryan · Massachusetts General Hospital · R01 · FY2017 · AI

O-Specific Polysaccharide Responses and Cholera

$779,448
Edward T. Ryan · Massachusetts General Hospital · R01 · FY2015 · AI

O-Specific Polysaccharide Responses and Cholera

$779,448
Edward T. Ryan · Massachusetts General Hospital · R01 · FY2016 · AI

Clinical analysis and therapeutic development of exosomal ACE2

$779,400
Huiping Liu · Northwestern University At Chicago · R01 · FY2022 · AI

Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases

$779,398
M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2016 · AI

Tulane National Primate Research Center

$779,363
Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2010 · RR

Genetics of Coxiella burnetii

$779,281
Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Identifying the burden of hospitalization due to Rhinovirus (RV) in children and mechanisms of pathogenesis using airway molecular profiling

$779,170
Ellen R. Wald · University Of Wisconsin-Madison · R01 · FY2025 · AI

TISSUE BIOSPECIMEN AND PATHOLOGY RESOURCE

$779,162
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P30 · FY2013 · CA

Immune engineering of optimized sequential immunization strategies for HIV vaccines

$779,142
Darrell J Irvine · Massachusetts Institute Of Technology · R61 · FY2022 · AI

Immune engineering of optimized sequential immunization strategies for HIV vaccines

$779,142
Darrell J Irvine · Massachusetts Institute Of Technology · R61 · FY2023 · AI

Project 2

$779,124
Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2024 · AI

The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response

$779,116
Albert C Shaw · Yale University · R01 · FY2021 · AG

Biocontainment Research Support Service(s) Core

$779,113
Dominique M Missiakas · University Of Chicago · UC7 · FY2025 · AI

Biocontainment Research Support Service(s) Core

$779,113
Dominique M Missiakas · University Of Chicago · UC7 · FY2024 · AI

Vaccines and therapies against botulism

$779,069
Joseph T. Barbieri · University Of Chicago · U54 · FY2013 · AI

Project 4: PK-PD of a Combination Antiretroviral Intravaginal Ring in Women

$779,012
Kathleen Listiak Vincent · Oak Crest Institute Of Science · U19 · FY2016 · AI